CA20737-6 - 0x00000000000032F7

Study Number: CA20737
Group Number: 6
Study Requirement: Healthy Male and Female
Stipend: $3,600.00

Study Criteria:

  • Age: 19 - 55
  • BMI: 19 - 30
  • Weight Restriction: minimum weight 111 lbs

Study Information:

  • Indication: This investigational medication is being developed to help cancer patients fight infection.
  • Route of Administration: Injection subcutaneous
  • Blood Draws: 10

Study Schedule:

  • Schedule Type: Short Term
  • Study Length: Two - 2 Night Stays, 5 Returns & 2 Phone Calls

Screening Dates: (appointments available in Lincoln and Omaha)

Event Day Event Date
Monday 12/18/2017
Tuesday 12/19/2017

Doctor Exam Dates: (appointments available in Lincoln and Omaha)

Event Day Event Date
Monday 12/18/2017
Tuesday 12/19/2017

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Saturday 1/6/2018 4:00:00 PM Monday 1/8/2018 7:30:00 PM 1 Lincoln
Return Wednesday 1/10/2018 5:30:00 AM Wednesday 1/10/2018 6:30:00 AM 1 Lincoln
Return Sunday 1/14/2018 5:30:00 AM Sunday 1/14/2018 7:00:00 AM 1 Lincoln
Phone participant* Sunday 1/21/2018 7:00:00 AM 1 Lincoln
Phone participant* Sunday 1/21/2018 7:00:00 AM 1 Lincoln
Check-In Saturday 1/27/2018 4:00:00 PM Monday 1/29/2018 7:30:00 PM 2 Lincoln
Return Wednesday 1/31/2018 5:30:00 AM Wednesday 1/31/2018 6:30:00 AM 2 Lincoln
Return Sunday 2/4/2018 5:30:00 AM Sunday 2/4/2018 7:00:00 AM 2 Lincoln
Phone participant* Sunday 2/11/2018 7:00:00 AM 2 Lincoln
Phone participant* Sunday 2/11/2018 7:00:00 AM 2 Lincoln
Return Monday 3/5/2018 5:30:00 AM Monday 3/5/2018 7:45:00 AM 2 Lincoln